MRSA Prevention and Risk Management Education (2).pptx
1.
2.
3.
4.
5.
6.
7. This guideline focused only on treatment and not on prevention of MRSA infections, except
for recurrent MRSA SSTI, focusing only on patient education and environmental hygiene.
Unfortunately, treatment considerations for cancer patients are not emphasized or covered
in the practice guideline.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54. Alrabiah, K., Al Alola, S., Al Banyan, E., Al Shaalan, M., & Al Johani, S. (2016). Characteristics and risk factors of hospital acquired
Methicillin-resistant Staphylococcus aureus (HA-MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh,
Saudi Arabia. International Journal of Pediatrics and Adolescent Medicine, 3(2), 71-77.
https://doi.org/10.1016/j.ijpam.2016.03.006
Ariza-Heredia, E. J., & Chemaly, R. F. (2028). Update on infection control practices in cancer hospitals. CA: A Cancer Journal for
Clinicians, 68(5), 340-355. https://doi.org/10.3322/caac.21462
Calfee, D. P., Salgado, C. D., Milstone, A. M., Harris, A. D., Kubar, D. T., Moody, J., Aureden, K., Huang, S. S., Maragakis, L. L., &
Yokoe, D> S. (2014). Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute
care hospitals: 2014 update. Infection Control and Hospital Epidemiology, 35(7). https://doi.org/10.1086/676534
Coaia, J. E., Wilson, J. A., Bak, A., Marsden, G. L., Shimonovich, M., Loveday, H. P., Humprheys, H., Wigglesworth, N., Demirjian,
A., Brooks, J., Butcher, L., Price, J. R., Ritchie, L., Newsholme, W., Enoch, D. A., Bostock, J., Cann, M., & Wilson, A. P.
(2021). Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and
control of methicillin-resistant Staphylococcis aureus (MRSA) in healthcare facilities. Journal of Hospital Infection, 118, S1-
S39. https://doi.org/10.1016’j.jhin.2021.09.022
Hadied, M. O., Bardossy, A. C, Abreu-Lanfracno, O/. Perri, M. B., Arshad, S., Zervocs, M., & Alangaden, G. (2015). Predictors of
mortality in cancer patients with methicillin-resistant Staphylococcus aureus bloodstream infection. Open Forum Infectious
Diseases, 2(suppl_1), 838. https://doi.org/10.1093/ofid/ofv133.555
Li, Z., Zhaung, H., Wang, G., Wang, H., & Dong, Y. (2021). Prevalence, predictors, and mortality of bloodstream infections due to
methicillin-resistant Staphylococcus aureus in patients with malignancy: Systematic review and meta-analysis. BMC
Infectious Diseases, 21, 74. https://doi.org/10.1186/s12879-021-05763-y
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R>, S., Fridkin, S. K., Gorwitz, R> J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E.,
Rybak, M. J., Talan, D. A., & Chambers, H. E. (2011). Clinical practice guidelines by the Infectious Diseases Society of America for
the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases, 52(3),
e18-e55. https://doi.org/10.1093/cid/ciq146
